CIK: 0001609251 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 15, 2025
Total Value ($000): $189 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS CORP | 101,146 | $29 | 15.4% | $146.00 | +104.7% | COM | 91307C102 |
| CAH | CARDINAL HEALTH INC | 133,745 | $22 | 11.9% | $56.53 | +160.2% | COM | 14149Y108 |
| EXEL | EXELIXIS INC | 493,526 | $22 | 11.5% | $18.73 | +113.4% | COM | 30161Q104 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 164,816 | $17 | 9.3% | $117.74 | -7.7% | COM | G50871105 |
| ENTA | ENANTA PHARMACEUTICALS INC | 2,114,444 | $16 | 8.5% | $22.16 | -72.9% | COM | 29251M106 |
| SUPN | SUPERNUS PHARMACEUTICALS INC | 472,376 | $15 | 7.9% | $35.15 | -8.8% | COM | 868459108 |
| — | INDIVIOR PLC | 974,474 | $14 | 7.6% | $0.01 | — | COM | G4766E116 |
| GSK | GSK PLC-SPON ADR | 271,729 | $10 | 5.5% | $0.04 | — | COM | 37733W204 |
| — | AVADEL PHARMACEUTICALS | 958,877 | $8 | 4.5% | $0.01 | — | COM | G29687103 |
| BNTX | BIONTECH SE-ADR | 73,382 | $8 | 4.1% | $0.09 | — | COM | 09075V102 |
| SNY | SANOFI-ADR | 148,946 | $7 | 3.8% | $0.05 | — | COM | 80105N105 |
| JNJ | JOHNSON & JOHNSON | 40,000 | $6 | 3.2% | $150.84 | 0.0% | COM | 478160104 |
| ALKS | ALKERMES PLC | 207,822 | $6 | 3.1% | $18.83 | +58.1% | COM | G01767105 |
| VNDA | VANDA PHARMACEUTICALS INC | 1,024,883 | $5 | 2.6% | $4.77 | -8.4% | COM | 921659108 |
| REGN | REGENERON PHARMACEUTICALS | 4,000 | $2 | 1.1% | $556.12 | 0.0% | COM | 75886F107 |